IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma
- 9 March 2011
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 407 (2), 348-354
- https://doi.org/10.1016/j.bbrc.2011.03.021
Abstract
No abstract availableFunding Information
- National Nature Science Foundation of China (30870516)
- Youth Scientist Foundation of Chongqing (2008BA5035)
- National Key Basic Research Program of China (2010CB529404)
This publication has 23 references indexed in Scilit:
- Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patientsLung Cancer, 2010
- Blockade of Tumor Necrosis Factor α Signaling in Tumor-Associated Macrophages as a Radiosensitizing StrategyCancer Research, 2010
- Protumor vs Antitumor Functions of IL-17The Journal of Immunology, 2009
- IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell linesBreast Cancer Research, 2008
- Generation and regulation of human CD4 + IL-17-producing T cells in ovarian cancerProceedings of the National Academy of Sciences of the United States of America, 2008
- Cancer-related inflammationNature, 2008
- TH17 cells in development: an updated view of their molecular identity and genetic programmingNature Reviews Immunology, 2008
- High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomasGut, 2008
- Expression and function of pro‐inflammatory interleukin IL‐17 and IL‐17 receptor in normal, benign hyperplastic, and malignant prostateThe Prostate, 2003
- Expression of IL-17 mRNA in Ovarian CancerBiochemical and Biophysical Research Communications, 2001